Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Surmodics Inc
(NQ:
SRDX
)
40.06
+0.34 (+0.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Surmodics Inc
< Previous
1
2
3
Next >
Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results
July 31, 2024
From
Surmodics, Inc.
Via
Business Wire
SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX
July 17, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, SRDX, AGS, VAPO on Behalf of Shareholders
July 08, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
July 04, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
June 10, 2024
From
Surmodics, Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
June 06, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
May 30, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
May 29, 2024
From
Halper Sadeh LLC
Via
Business Wire
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
May 29, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
May 01, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
April 19, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Participate in Upcoming Investor Conferences in March and April
February 27, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
February 01, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
January 22, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
January 16, 2024
From
Surmodics, Inc. Surmodics, Inc.
Via
Business Wire
Surmodics to Host Virtual Annual Meeting of Shareholders
January 16, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
November 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
November 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
November 14, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
November 08, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
November 07, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
November 07, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
October 31, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
October 10, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Participate in Upcoming Investor Conferences in August
August 09, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
August 02, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2
July 12, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon
June 20, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System
June 14, 2023
From
Surmodics, Inc.
Via
Business Wire
Surmodics to Participate in the Jefferies Healthcare Conference on June 8
May 25, 2023
From
Surmodics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.